NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.
Read Original Story

Reuters Health provides balanced look at alternative remedies for premature ejaculation

Rating

4 Star

Categories

Alternative medicine might help treat premature ejaculation

Our Review Summary

This report of a systematic review of complementary medicine to treat premature ejaculation is fairly complete and includes important limitations of the research.

Some additional context would have been helpful, including information about prescribed treatments that have been approved in other countries, such as SSRI antidepressants, but not in the U.S.

 

Why This Matters

While the problem itself–how exactly one defines “premature” may be open to debate and discussion–it is clear that this is an issue that many men may experience, yet may not want to consult their clinician about. Many may turn to alternative remedies as a result, and this study helps provide some insight into their effectiveness. We were pleased to see that the story made clear that there were limitations to the data, and that the placebo effect could have played a big role.

Criteria

Does the story adequately discuss the costs of the intervention?

Not Satisfactory

There were no discussions of cost here, apart from the fact that the products in question would likely be available without a prescription and hence, the costs pertaining to a doctor’s visit would not be relevant here.

Does the story adequately quantify the benefits of the treatment/test/product/procedure?

Satisfactory

While we don’t really know what particular ingredients might be in the tested Chinese herbal treatments, the Ayurvedic herbal medicine or the Korean topical cream, we do learn that “Chinese herbal medicine increased IELT by about two minutes, Ayurvedic herbal medicine increased IELT by nearly a minute and topical cream increased IELT by more than eight minutes.”  We would have benefited from knowing what the baseline times were, ie: if the two acupuncture studies were found to increase intravaginal ejaculatory latency time (IELT) by about half a minute compared to placebo, how much additional time did the placebo provide?

Does the story adequately explain/quantify the harms of the intervention?

Satisfactory

The report helpfully mentioned that “some studies, but not all, discussed side effects such as gastrointestinal discomfort, dizziness, mild pain and decreased libido. When they were reported, the adverse effects were generally mild.”

It would have been useful to note that the off-label use of SSRIs also involves some rate of adverse effects and that some foreign-sourced herbal treatments have been found to be adulterated with compounds from prescription drugs, and that quality control of herbal treatments is sometimes a problem.

Does the story seem to grasp the quality of the evidence?

Satisfactory

The report explained this was a systematic review looking at a group of studies. The story noted that there were limitations, such as the “underlying weakness of the studies evaluated,” adding “Bias was unclear in most of the studies, and only five used stopwatches to measure IELT, which is the ‘gold standard’ for premature ejaculation studies.”

We’re also told that “the studies are so different, it’s tough to draw conclusions about the different options. For example, the five Chinese medicine studies tested different substances, including Qilin pills, Yimusake and Uighur.”

Does the story commit disease-mongering?

Satisfactory

Even though the prevalence of premature ejaculation is a subject open to disease-mongering, this report did not veer in that direction, noting how difficult to measure it is.  “Some studies suggest that between 20 and 30 percent of men report early ejaculation concerns, but the International Society for Sexual Medicine estimates that about 4 percent of men have a lifelong condition.”

Does the story use independent sources and identify conflicts of interest?

Satisfactory

The researchers interviewed don’t appear to have any conflicts of interest, and several independent sources were included.

Does the story compare the new approach with existing alternatives?

Satisfactory

The study noted that the various alternatives were compared against placebo or alternative treatments. It would have been useful to know how the various herbal remedies compared against what is considered by many physicians to be a reference standard–the off-label use of an SSRI antidepressant, such as paroxetine.

Does the story establish the availability of the treatment/test/product/procedure?

Not Satisfactory

It’s not clear how available these products are. Considering how many products are sold online for this problem, some information on what these products are, and how available they are, would be useful.

Does the story establish the true novelty of the approach?

Satisfactory

The study establishes its novelty right up front, saying it is the first systematic review of the alternatives to treat premature ejaculation. Based on a literature search we conducted, this appears to be accurate.

Does the story appear to rely solely or largely on a news release?

Satisfactory

The range of quoted experts and the comprehensiveness of this story would suggest there isn’t an over-reliance on a news release.

Total Score: 8 of 10 Satisfactory

Comments (1)

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Gary Schwitzer

February 1, 2017 at 10:50 am

We may have been too lenient on our application of the disease-mongering criterion. Our analysis only commented on prevalence statistics, but the bigger concern is whether a condition has been framed as a disease requiring treatment when, in fact, there are important questions about that framing and assumption. Indeed, the marketing of treatments for premature ejaculation has been cited as a prime example of disease-mongering.

Some reading on the topic:

Sure, it’s treatable. But is it a disorder?

Is premature ejaculation a disease?

Medicalization, wish-fulfilling medicine and disease-mongering

Disease mongering: expanding the boundaries of treatable disease

As publisher, I felt compelled to add this perspective to our review. The story could have addressed these concerns with even one sentence, but didn’t. That was the biggest thing that jumped out at me when I read the story.

Gary Schwitzer
Publisher
HealthNewsReview.org

Reply